Evidence-based clinical guidelines for chronic constipation 2023
Eikichi Ihara,Noriaki Manabe,Hidenori Ohkubo,Naotaka Ogasawara,Haruei Ogino,Kazuki Kakimoto,Motoyori Kanazawa,Hidejiro Kawahara,Chika Kusano,Shiko Kuribayashi,Akinari Sawada,Tomohisa Takagi,Shota Takano,Toshihiko Tomita,Toshihiro Noake,Mariko Hojo,Ryota Hokari,Tatsuhiro Masaoka,Tomohiko Machida,Noboru Misawa,Yoshiyuki Mishima,Hiroshi Yajima,Sayuri Yamamoto,Hiroshi Yamawaki,Tatsuya Abe,Yasumi Araki,Kunio Kasugai,Takeshi Kamiya,Akira Torii,Atsushi Nakajima,Koji Nakada,Shin Fukudo,Yasuhiro Fujiwara,Hiroto Miwa,Hiromi Kataoka,Akihito Nagahara,Kazuhide Higuchi
DOI: https://doi.org/10.1159/000540912
2024-08-19
Digestion
Abstract:In July 2023 the Japan Gastroenterological Association published the first version of its clinical guidelines for chronic constipation 2023. Based on the latest evidence, these guidelines describe the definition, classification, diagnostic criteria, diagnostic testing methods, epidemiology, pathophysiology, and treatment of chronic constipation. They include flowcharts for both diagnosis and treatment of chronic constipation. In the treatment of chronic constipation, the first step involves differentiating between secondary forms, such as organic disease-associated constipation, systemic disease-associated constipation, and drug-induced constipation. The next step is to determine whether the chronic constipation stems from a motility disorder, a form of primary chronic constipation. For functional constipation and constipation-predominant irritable bowel syndrome, treatment should be initiated after evaluating symptoms like reduced frequency of bowel movement frequency type or defecation difficulty type. The first line of treatment includes improvement of lifestyle habits and diet therapy. The first drugs to consider for oral treatment are osmotic laxatives. If these are ineffective, secretagogues and ileal bile acid transporter inhibitors are candidates. However, stimulant laxatives are exclusively designated for as-needed use. Probiotics, bulk-forming laxatives, prokinetics, and Kampo medicine, for which there is insufficient evidence, are considered alternative or complementary therapy. Providing the best clinical strategies for chronic constipation therapy in Japan, these clinical guidelines for chronic constipation 2023 should prove useful for its treatment worldwide.